Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1165]

The future of cancer prevention

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United...

The future of cancer prevention ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )

Update on CaPP3 in high risk populations

Prof Sir John Burn – Institute of Genetic Medicine, Newcastle, UK

Update on CaPP3 in high risk populations ( Prof Sir John Burn – Institute of Genetic Medicine, Newcastle, UK )

Surgical advances in colorectal cancer care

Prof Jaffer Ajani - University of Texas MD Anderson Cancer Center, Houston, USA

Surgical advances in colorectal cancer care ( Prof Jaffer Ajani - University of Texas MD Anderson Cancer Center, Houston, USA )

miRNA screening through nipple aspiration sampling

Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands

miRNA screening through nipple aspiration sampling ( Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands )

Breast cancer in the 21st century

Prof Debu Tripathy - MD Anderson Cancer Center, Texas, USA

Breast cancer in the 21st century ( Prof Debu Tripathy - MD Anderson Cancer Center, Texas, USA )

Review of olaparib for ovarian cancer

Dr Michel Vulfovich - Memorial Cancer Institute, Hollywood, Florida, USA

Review of olaparib for ovarian cancer ( Dr Michel Vulfovich - Memorial Cancer Institute, Hollywood, Florida, USA )

Lung cancer immunotherapy

Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA

Lung cancer immunotherapy ( Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA )

'Other' targets in lung cancer

Dr Edward Garon - David Geffen School of Medicine at the University of...

'Other' targets in lung cancer ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

Prof Michael Seckl - Imperial College London, London

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer? ( Prof Michael Seckl - Imperial College London, London )

Polycomb repressors and epigenetic therapy

Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK

Polycomb repressors and epigenetic therapy ( Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK )

DNA repair and mutations as targets for personalised therapy

Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA

DNA repair and mutations as targets for personalised therapy ( Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA )

The changing process of drug discovery and design

Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK

The changing process of drug discovery and design ( Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK )

More from ecancer